FolioMetrix’s Bausch Health BHC Stock Holding History

FolioMetrix’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$146K	Buy	+674	New	+$149K	0.06%	189

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

FolioMetrix's BHC Position: Q2 2015 in Review

FolioMetrix opened a new position in Bausch Health (BHC) in Q2 2015: 674 shares worth $146K. The stake represents 0.06% of the portfolio and ranks #189 among its holdings.

582 funds tracked by Wall St. Rank hold BHC as of Q2 2015.

FolioMetrix held 674 shares of Bausch Health worth $146K as of Q2 2015.
Bausch Health was a new FolioMetrix position in Q2 2015.
Bausch Health made up 0.06% of FolioMetrix's portfolio in Q2 2015, its #189 holding.
582 funds tracked by Wall St. Rank held Bausch Health as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.